Literature DB >> 20573383

Ultrasound-guided minimally invasive percutaneous nephrolithotomy in flank position for management of complex renal calculi.

Yi-Ming Fu1, Qi-Yin Chen, Zhong-Shan Zhao, Ming-Hua Ren, Li Ma, Yong-Shun Duan, Zhi-Xing Jiao, Wei Huang, Shao-Bin Ni.   

Abstract

OBJECTIVES: To evaluate the safety and efficacy of performing ultrasound-guided minimally invasive percutaneous nephrolithotomy (MPCNL) in the flank position for the management of complex renal calculi. Percutaneous nephrolithotomy is usually performed with the patient in the prone position under fluoroscopic guidance; however, this position, and guidance method have some limitations.
METHODS: From January 2007 to December 2009, 93 patients (101 kidneys) with complex renal calculi underwent ultrasound-guided MPCNL in the flank position.
RESULTS: The mean age of the patients was 45.3 years (range 29-71). The calculi-free rate in the patients who underwent a single procedure was 78.2% (79 of 101 kidneys). The average operative duration was 82.6 minutes (range 45-190). Although the perioperative blood loss was not significantly different between single-tract and double-tract MPCNL (P = .087, F = 2.981), the calculi-free rate was significantly greater in the patients who underwent double-tract MPCNL than in those who underwent single-tract MPCNL (P = .027, chi-square = 4.873). Perioperative blood transfusions were not required in any patient. Similarly, ureteral calculi due to percutaneous nephrolithotomy were not observed. Secondary renal hemorrhage occurred in 3 patients who had undergone single-tract MPCNL and 1 underwent nephrectomy.
CONCLUSIONS: The results of our study have shown that ultrasound-guided MPCNL with the patient in the flank position is safe and effective for treating complex renal calculi, without the side effects of radiation to the patient and surgeon. Double-tract MPCNL is suitable for complex renal calculi and, in some cases, is required to increase the calculi-free rate. The insertion of twin ureteral catheters before lithotripsy might be helpful in avoiding residual ureteral calculi after percutaneous nephrolithotomy. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20573383     DOI: 10.1016/j.urology.2010.04.054

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Ultrasound Guidance Reduces Percutaneous Nephrolithotomy Cost Compared to Fluoroscopy.

Authors:  Matthew Hudnall; Manint Usawachintachit; Ian Metzler; David T Tzou; Brittany Harrison; Errol Lobo; Thomas Chi
Journal:  Urology       Date:  2016-12-23       Impact factor: 2.649

2.  Treatment of large impacted proximal ureteral stones: randomized comparison of minimally invasive percutaneous antegrade ureterolithotripsy versus retrograde ureterolithotripsy.

Authors:  Xiao-Jian Gu; Jian Lin Lu; Yan Xu
Journal:  World J Urol       Date:  2013-01-20       Impact factor: 4.226

3.  Image-Guided Abdominal Surgery and Therapy Delivery.

Authors:  Robert L Galloway; S Duke Herrell; Michael I Miga
Journal:  J Healthc Eng       Date:  2012-06       Impact factor: 2.682

4.  Percutaneous puncture of renal calyxes guided by a novel device coupled with ultrasound.

Authors:  Chen Jen Chan; Victor Srougi; Fabio Yoshiaki Tanno; Ricardo Duarte Jordão; Miguel Srougi
Journal:  Int Braz J Urol       Date:  2015 Sep-Oct       Impact factor: 1.541

5.  Clinical comparison of the efficiency and security of balloon dilators versus fascial dilators in percutaneous nephrolithotripsy (PCNL).

Authors:  Lingbo Yang; Shuaiqi Lu; Xingtao Han; Pengtao Wei; Jinhui Yang; Tongtong Hao
Journal:  Pak J Med Sci       Date:  2016 May-Jun       Impact factor: 1.088

6.  Complete supine PCNL: ultrasound vs. fluoroscopic guided: a randomized clinical trial.

Authors:  Siavash Falahatkar; Aliakbar Allahkhah; Majid Kazemzadeh; Ahmad Enshaei; Maryam Shakiba; Fahimeh Moghaddas
Journal:  Int Braz J Urol       Date:  2016 Jul-Aug       Impact factor: 1.541

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.